Bioresponsive nanogels for protein delivery-Reference-Cited by-同舟云学术

Bioresponsive nanogels for protein delivery

Published:2022-01 Issue:1 Volume:3 Page:20200136
ISSN:2688-268X
Container-title:VIEW
language:en
Short-container-title:VIEW

Author:

Xu Xiao¹,Shen Shiyang¹,Mo Ran¹^ORCID

Affiliation:

1. State Key Laboratory of Natural Medicines Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases Center of Advanced Pharmaceuticals and Biomaterials School of Life Science and Technology China Pharmaceutical University Nanjing China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/VIW.20200136

Reference74 articles.

1. Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer

2. Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma

3. Burosumab treatment of children with X-linked hypophosphataemic rickets

4. Pegvaliase: a novel treatment option for adults with phenylketonuria

5. Ibalizumab: The First Monoclonal Antibody for the Treatment of HIV-1 Infection

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polymer-mediated protein/peptide therapeutic stabilization: Current progress and future directions;Progress in Polymer Science;2024-09

2. Advances in Drug Delivery Systems for the Treatment of Acute Myeloid Leukemia;Small;2024-06-27

3. Near-infrared light-activated smart nanogels for remotely controlled cytochrome c release and photodynamic therapy;European Polymer Journal;2024-04

4. Application of Bioactive Materials for Osteogenic Function in Bone Tissue Engineering;Small Methods;2024-03-21

5. Nanoplatform‐Based In Vivo Gene Delivery Systems for Cancer Therapy;Small;2024-03-05